ADM has agreed to purchase US company Deerland Probiotics and Enzymes, as it looks to expand its portfolio of health and wellness products and solutions.
Deerland is a global provider of supplements that use probiotic, prebiotic, and enzyme technology. The brand serves consumers in sectors such as digestive, immune and women’s health, food intolerance, sports nutrition, cellular repair and systemic and cardiovascular health.
Deerland’s products include spore probiotics, which offer enhanced stability for wider use in food and beverage, pet nutrition and supplement applications.
The company operates five manufacturing sites and one fermentation facility, as well as eight research and development laboratories globally.
Juan Luciano, ADM’s Chairman and CEO, said: “Deerland Probiotics and Enzymes is a leader in probiotic, prebiotic and enzyme technology, with global sales and manufacturing in the US and Europe, and is a perfect fit for our growing portfolio of functional ingredients and solutions for health-conscious consumers”.
He continued: “We expect the addition of the Deerland capabilities and portfolio to deliver synergies for our health and wellness business and support growth across our nutrition business unit”.
The transaction is subject to regulatory approval and is expected to be completed in the coming weeks.
The announcement comes after ADM made a leading equity investment in Slovenian biotechnology company Acies Bio.
© FoodBev Media Ltd 2024